POST-CONFERENCE WORKSHOPS

9:00 – 12:00 PM (Registration begins at 8:30 AM – Breakfast will be served)

ADiversity, Equity, and Inclusion Working Group: How In-House Counsel and Their Law Firm Partners Can Collaborate to Implement Successful DEI Initiatives

Successful diversity, equity and inclusion initiatives are far more complex than merely generating a list of general objectives. Implementing effective DE&I programs for the pharmaceutical IP bar requires a dedication to building these initiatives into your company’s DNA and operating behaviors. As many in the legal industry have seen however, this is not always as simple as it sounds, and often requires a commitment to collaboration between in-house counsel and their law firm partners. Join this important working group for a discussion of what DEI initiatives are currently working to yield lasting effects and overcoming the latest challenges life sciences companies and law firms are facing in this endeavor. Gain and share insights on topics including:

• Growing the awareness of the pharmaceutical IP practitioners among underrepresented racial and ethnic groups

» Championing their representation in the pharmaceutical IP work force

» Advocating for diverse and young attorneys appearing in the court room

• Reviewing data showing the benefits of a diverse workforce

• Accelerating the advancement of a more diverse pharmaceutical IP community via mentoring and networking

• Understanding what specific evidence of diversity pharmaceutical companies, and IP departments, are seeking from their law firm counterparts

• Implementing organizational changes that promote diversity

» How clients can seek out partnerships with firms that promote:

» Utilizing NAMWOLF lists

1:00 – 4:00 (Registration begins at 12:30 PM)

BA Comprehensive Handbook for Pharmaceutical Patent Litigation Funding Arrangements

Litigation funding can help businesses pay for legal fees and expenses, including increasingly costly expert fees. Financing can provide risk averse litigants with the confidence to see cases through to their conclusion, even against the best-capitalized defendants. In this interactive workshop, topics of discussion will include:

• Reviewing litigation funding and its advantages for litigants

• Recognizing the essential criteria of a feasible funding opportunity based on meritorious claims

• Analyzing the mechanics of the financer’s underwriting process

• Exploring the key modules of a pharmaceutical patent litigation funding agreement

About us:

The C5 Group, comprising American Conference Institute, The Canadian Institute and C5 in Europe, is a leading global events and business intelligence company.

For over 30 years, C5 Group has proVided the opportunities that bring together business leaders, professionals and international experts from around the world to learn, meet, network and make the contacts that create the opportunities.

Our conferences and related products connect the power of people with the power of information, a powerful combination for business growth and success.

Continuing Legal Education Credits

Accreditation will be sought in those jurisdictions requested by the registrants which have continuing education requirements. This course is identified as nontransitional for the purposes of CLE accreditation.

ACI certifies this activity has been approved for CLE credit by the New York State Continuing Legal Education Board.

ACI certifies this activity has been approved for CLE credit by the State Bar of California.

ACI has a dedicated team which processes requests for state approval. Please note that event accreditation varies by state and ACI will make every effort to process your request.

Questions about CLE credits for your state? Visit our online CLE Help Center at www.AmericanConference.com/Accreditation/CLE/